Israel Englander Matinas Bio Pharma Holdings, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.72 $67,952 - $139,788	-194,150 Reduced 91.61%	17,777 $6,000
Q1 2023 May 15, 2023	SELL	$0.39 - $0.6 $10,714 - $16,484	-27,474 Reduced 11.48%	211,927 $100,000
Q4 2022 Feb 14, 2023	BUY	$0.46 - $42.69 $110,124 - $10.2 Million	239,401 New	239,401 $120,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $22,056 - $32,349	-29,409 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$0.96 - $1.74 $393,142 - $712,570	-409,523 Reduced 93.3%	29,409 $31,000
Q4 2020 Feb 16, 2021	BUY	$0.76 - $1.47 $296,646 - $573,776	390,324 Added 803.0%	438,932 $597,000
Q3 2020 Nov 16, 2020	SELL	$0.67 - $0.96 $235,278 - $337,115	-351,162 Reduced 87.84%	48,608 $37,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $290,543 - $514,038	-558,737 Reduced 58.29%	399,770 $309,000
Q1 2020 May 14, 2020	BUY	$0.6 - $2.31 $518,535 - $2 Million	864,225 Added 916.64%	958,507 $575,000
Q4 2019 Feb 14, 2020	SELL	$0.63 - $2.27 $185,376 - $667,942	-294,248 Reduced 75.73%	94,282 $214,000
Q3 2019 Nov 14, 2019	SELL	$0.59 - $0.9 $107,847 - $164,513	-182,793 Reduced 31.99%	388,530 $244,000
Q2 2019 Aug 15, 2019	BUY	$0.79 - $1.11 $436,647 - $613,516	552,718 Added 2970.8%	571,323 $489,000
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $750,739 - $1.05 Million	-950,303 Reduced 98.08%	18,605 $212,000
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $581,344 - $1.37 Million	968,908 New	968,908 $1.06 Million
Q4 2018 Feb 14, 2019	SELL	$0.53 - $1.11 $39,652 - $83,045	-74,816 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$0.35 - $0.92 $51,968 - $136,603	-148,482 Reduced 66.49%	74,816 $69,000
Q2 2018 Aug 14, 2018	BUY	$0.42 - $0.74 $93,785 - $165,240	223,298 New	223,298 $97,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account